Oppositional Defiant Disorder Completed Phase 2 Trials for Ziprasidone (DB00246)

Also known as: Conduct Disorder / Disruptive Behavior Disorders / Disruptive behaviour disorder / Disruptive Behavior Disorder / Conduct Disorders / Behavior Disorder, Disruptive / Conduct behavior disorder / Conduct behaviour disorder / Unspecified disturbance of conduct

IndicationStatusPhase
DBCOND0032311 (Oppositional Defiant Disorder)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00676429Ziprasidone for Severe Conduct and Other Disruptive Behavior DisordersTreatment